Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes

Circulation

Volumn 98, Issue 5, 1998, Pages 450-457

  Wessely, Rainer ^a,c   Henke, Andreas ^b   Zell, Roland ^b   Kandolf, Reinhard ^d   Knowlton, Kirk U ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d San Diego ^*

Author keywords

Heart failure; Myocarditis; Viruses

Indexed keywords

COMPLEMENTARY DNA; LACTATE DEHYDROGENASE; RNA DIRECTED RNA POLYMERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; DIAGNOSTIC APPROACH ROUTE; DNA DETERMINATION; GENE EXPRESSION REGULATION; HEART DILATATION; HEART MUSCLE CELL; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0032483055     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.5.450     Document Type: Article

References (40)

1. Billingham ME, Tazelaar HD. The morphological progression of viral myocarditis. Postgrad Med J. 1986;62:581-584.
2. McManus BM, Kandolf R. Evolving concepts of cause, consequence, and control in myocarditis. Curr Opin Cardiol. 1991;6:418-427.
3. Kandolf R, Klingel K, Zell R, Selinka HC, Raab U, Schneider-Brachert W, Bultmann B. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology. 1993; 35:140-151.
4. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182-188.
5. Rueckert RR. Picornaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fundamental Virology. New York, NY: Raven Press; 1996:477-522.
6. Lee WM, Monroe SS, Rueckert RR. Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol. 1993; 67:2110-2122.
7. Ansardi DC, Morrow CD. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. J Virol. 1995;69:1540-1547.
8. Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbere-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology. 1992;186:398-408.
9. Brahic M, Stroop WG, Baringer JR. Theiler's virus persists in glial cells during demyelinating disease. Cell. 1981;26:123-128.
10. Carp RI. Persistent infection of human lymphoid cells with poliovirus and development of temperature-sensitive mutants. Intervirology. 1981;15: 49-56.
11. Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A. 1989;86:7590-7594.
12. de la Torre JC, Davila M, Sobrino F, Ortin J, Domingo E. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology. 1985;145:24-35.
13. Sharief MK, Hentges R, Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med. 1991;325:749-755.
14. Kandolf R, Canu A, Hofschneider PH. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol. 1985;17:167-181.
15. Gratsch TE, Righthand VF. Construction of a recombinant cDNA of echovirus 6 that established a persistent in vitro infection. Virology. 1994;201:341-348.
16. Matteucci D, Paglianti M, Giangregorio AM, Capobianchi MR, Dianzani F, Bendinelli M. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol. 1985;56:651-654.
17. Cao Y, Schnurr DP. Persistent infection of YAC-1 cells by coxsackievirus B3. J Gen Virol. 1988;69:59-65.
18. Heim A, Brehm C, Stille-Siegener M, Muller G, Hake S, Kandolf R, Figulla HR. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication. J Mol Cell Cardiol. 1995;27:2199-2208.
19. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad SCI U S A. 1992;89:314-318.
20. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A. 1985;82:4818-4822.
21. Klump WM, Bergmann I, Muller BC, Ameis D, Kandolf R. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J Virol. 1990;64:1573-1583.
22. Knowlton KU, Baracchini E, Ross RS, Harris AN, Henderson SA, Evans SM, Glembotski CC, Chien KR. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells: identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem. 1991;266:7759-7768.
23. Stanssens P, Opsomer C, McKeown YM, Kramer W, Zabeau M, Fritz HJ. Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res. 1989;17:4441-4454.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
25. Mackett M, Smith GL, Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol. 1984;49:857-864.
26. Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol. 1985;5:3403-3409.
27. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. α- and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells: fos/jun expression is associated with sarcomere assembly; egr-1 induction is primarily an α 1-mediated response. J Biol Chem. 1990;265:13809-13817.
28. Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995; 69:6720-6728.
29. 1 165,000 M-protein myomesin: a specific protein of cross-striated muscle cells. J Cell Biol. 1981;89:185-193.
30. Kammerer U, Kunkel B, Korn K. Nested PCR for specific detection and rapid identification of human picornaviruses. J Clin Microbiol. 1994;32: 285-291.
31. 1-adrenergic stimulation. J Biol Chem. 1994;269:13490-13496.
32. Shubeita HE, Thorburn J, Chien KR. Microinjection of antibodies and expression vectors into living myocardial cells. Development of a novel approach to identify candidate genes that regulate cardiac growth and hypertrophy. Circulation. 1992;85:2236-2246.
33. Kandolf R, Hofschneider PH. Viral heart disease. Springer Semin Immunopathol. 1989;11:1-13.
34. Martino TA, Liu P, Martin P, Sole MJ. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In: Rotbart HA, ed. Human Enterovirus Infections. Washington, DC: American Society for Microbiology; 1995:291-351.
35. Yoneda S, Senda K, Hayashi K. Experimental study of virus myocarditis in culture. Jpn Circ J. 1979;43:1048-1054.
36. Herzum M, Ruppert V, Kuytz B, Jomaa H, Nakamura I, Maisch B. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol. 1994;26:907-913.
37. Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skem T, Rhoads RE. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human coxsackievirus and rhinovirus. J Biol Chem. 1993;268:19200-19203.
38. Lamphear BJ, Kirchweger R, Skem T, Rhoads RE. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases: implications for cap-dependent and cap-independent translational initiation. J Biol Chem. 1995;270: 21975-21983.
39. Das S, Dasgupta A. Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. J Virol. 1993;67:3326-3331.
40. Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol. 1993;13:1232-1237.